Princeton, New Jersey; June 1, 2011 - Sandoz today announced the US Food and Drug Administration (FDA) approval and US launch of donepezil hydrochloride (HCL) film-coated tablets and donepezil HCL ...
(HealthDay News) – For patients with dementia with Lewy bodies (DLB), 5 and 10mg/day doses of donepezil are associated with significant improvements in behavioral, cognitive, and global symptoms, ...
Credit: Shutterstock. Adlarity is a once-weekly transdermal formulation of donepezil that is designed to be worn for 7 days with consistent adhesion. The Food and Drug Administration (FDA) has ...
July 27, 2010 — The US Food and Drug Administration (FDA) has approved donepezil HCl 23-mg tablets (Aricept; Eisai, Inc and Pfizer, Inc) for the once-daily treatment of moderate to severe Alzheimer's ...
Salzburg, Austria - Treatment with ARICEPT® (donepezil hydrochloride tablets) significantly improved the cognitive and global (overall) function of patients with vascular dementia (VaD), compared with ...
ARICEPT® efficacy and safety study in new treatment area presented at the American Association for Geriatric Psychiatry's (AAGP) 15th annual meeting Orlando, Florida (February 26, 2002) - Treatment ...
Gurgaon, India, Ranbaxy Pharmaceuticals Canada Inc. (RPCI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced that RPCI received approval on December 24, 2013 to manufacture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results